Board Meeting Details
The Board of Directors meeting commenced at 4:00 PM and concluded at 7:30 PM on May 30, 2026. The board approved:
- Audited Standalone & Consolidated Financial Results for Quarter & Year Ended March 31, 2026
- Auditor's Report on audited Standalone & Consolidated Financial Statements issued on May 30, 2026
Consolidated Financial Performance (Year Ended March 31, 2026)
- Total Income: ₹18,098.67 lakhs (vs ₹14,833.31 lakhs in FY25)
- Revenue from Operations: ₹17,274.09 lakhs (vs ₹13,790.30 lakhs in FY25)
- Other Income: ₹824.58 lakhs (vs ₹1,043.01 lakhs in FY25)
- Total Expenses: ₹15,714.90 lakhs (vs ₹12,678.35 lakhs in FY25)
- Net Profit for Period: ₹20,978.80 lakhs (vs ₹18,124.90 lakhs in FY25)
- Profit Attributable to Owners: ₹18,506.90 lakhs (vs ₹16,123.00 lakhs in FY25)
- EPS (Basic): ₹0.762 (vs not specified for FY25)
- Paid-up Equity Capital: ₹2,429.48 lakhs
Consolidated Financial Performance (Q4 Ended March 31, 2026)
- Total Income: ₹6,227.37 lakhs
- Revenue from Operations: ₹6,095.50 lakhs
- Net Profit for Period: ₹4,458.60 lakhs
- EPS (Basic): ₹0.156
Standalone Financial Performance (Year Ended March 31, 2026)
- Total Income: ₹12,799.68 lakhs (vs ₹10,379.92 lakhs in FY25)
- Revenue from Operations: ₹11,985.67 lakhs (vs ₹9,457.79 lakhs in FY25)
- Net Profit for Period: ₹16,128.10 lakhs (vs ₹14,036.80 lakhs in FY25)
- EPS (Basic): ₹0.666 (vs ₹0.617 in FY25)
Standalone Financial Performance (Q4 Ended March 31, 2026)
- Total Income: ₹3,801.20 lakhs
- Revenue from Operations: ₹3,671.41 lakhs
- Net Profit for Period: ₹2,994.40 lakhs
- EPS (Basic): ₹0.125
Key Balance Sheet Items (Consolidated as of March 31, 2026)
- Total Assets: ₹34,867.52 lakhs (vs ₹25,603.52 lakhs in FY25)
- Property, Plant & Equipment: ₹5,779.69 lakhs
- Capital Work-in-Progress: ₹1,331.71 lakhs
- Inventories: ₹5,388.75 lakhs (vs ₹3,593.99 lakhs in FY25)
- Trade Receivables: ₹4,355.65 lakhs (vs ₹1,416.11 lakhs in FY25)
- Total Equity: ₹23,283.60 lakhs (vs ₹19,458.93 lakhs in FY25)
- Borrowings (Current): ₹3,595.37 lakhs (vs ₹1,021.86 lakhs in FY25)
- Trade Payables: ₹2,029.88 lakhs (vs ₹1,315.95 lakhs in FY25)
Key Balance Sheet Items (Standalone as of March 31, 2026)
- Total Assets: ₹27,382.13 lakhs (vs ₹21,838.28 lakhs in FY25)
- Property, Plant & Equipment: ₹2,164.14 lakhs
- Capital Work-in-Progress: ₹518.14 lakhs
- Inventories: ₹4,162.58 lakhs (vs ₹2,458.56 lakhs in FY25)
- Trade Receivables: ₹3,336.65 lakhs (vs ₹1,189.07 lakhs in FY25)
Audit Qualifications
The statutory auditors, R Pugalia & Company, issued a qualified opinion for both standalone and consolidated financial statements citing:
- Management assured to get confirmations/reconciliations of balances of Current Assets, Other Non-Current Assets, Non-Current Liabilities, Current Liabilities & other Current Liabilities
- Impact of the same is unascertained
- Company is in process to install Transaction Traceability Software in its accounting systems
- Qualification is repetitive from previous years
Management Response to Audit Qualifications
Management acknowledges the qualification and states:
- Company made best efforts to obtain balance confirmations before signing accounts
- Management confirms balances shown in books are true and correct as per their knowledge
- Company is evaluating vendor solutions and upgrading accounting software for transaction traceability
- Appropriate measures are being taken
Segment Reporting
The company has only one reportable segment: "Bulk Drugs, Biotech Products and Intermediates".
Geographic Revenue Breakdown (Standalone)
Major markets for FY26 include:
- India: ₹8,402.32 lakhs (70.1% of revenue)
- Vietnam: ₹1,346.70 lakhs
- Colombia: ₹917.04 lakhs
- Mexico: ₹337.82 lakhs
- Egypt: ₹368.43 lakhs
Cash Flow Statement (Standalone)
- Net Cash from Operating Activities: (₹4,018.28) lakhs outflow
- Net Cash from Investing Activities: ₹162.37 lakhs inflow
- Net Cash from Financing Activities: ₹3,540.12 lakhs inflow
- Net Decrease in Cash: (₹315.80) lakhs
Additional Information
- Results prepared in accordance with Companies Act 2013 and Indian Accounting Standards (Ind-AS)
- Figures for quarter ended March 31, 2026 are balancing figures between audited full year and published unaudited YTD figures up to Q3